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Introduction: Roaccutane, Acuten, and Isotretinoin are derivatives of the 
vitamin A naturally found in human body. Since vitamin A is a fat-soluble 
vitamin, it is prescribed through controlling the amount of skin oil by forcing 
low-secreted sebaceous glands to treat severe skin acne with the risk of 
permanent scarring. Thus, we aimed to investigate the effects of Roaccutane on 
evolution of ovarian follicles and uterine, and possible attendant liver changes 
in adult NMRI mice.   
Materials and Methods: Roaccutane was orally administered by gavage at the 
doses of 0.5, 10, and 20 mg/kg for 21 days. Then, the mice were dissected, and 
the uterine, ovarian, and liver tissues were separated. The levels of Estradiol 
(E2), Follicle-stimulating hormone (FSH), Alanine transaminase (ALT), 
Aspartate transaminase (AST), and Alkaline phosphatase (ALP) were 
examined by ELISA test and chlorometric biochemical method.  
Results: Increase in the Roaccutane dose led to the damage to endometrium 
layers, and there were no significant changes in myometrium and perimetrium. 
Observations of the tissue of ovaries indicated the maturity of them. Significant 
reduction in the number of hepatocytes and rise of glands and blood vessels 
were the results of the liver damage. High level of liver enzymes (ALT, AST, 
and ALP) was the important reason for the liver damage. Hormonal findings 
through the increase of E2 and FSH also showed tissue damage.  
Conclusion: The results revealed the harmful effect of Roaccutane on 
evolution of ovarian follicles and uterine and liver changes of adult laboratory 
NMRI mice (either tissue or hormone).  
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     Isotretinoin is a retinoid that is derived 
from vitamin A and found naturally in small 
amounts in body [1, 2]. Oral isotretinoin is 
marketed as a gel capsule with various 
brands, the most famous of which are 
Acuten and Roaccutane from the Roche 
Pharmaceutical Factory [2, 3]. The topical 
form of the drug is also available in 
pharmacies under the brand name Isotrex or 
Isotrexin. Isotretinoin production in 1982 
was a major breakthrough in the treatment 
of acne. Since 1982, Roaccutane has been 
commercialized. The drug was licensed in 
the United States until 1991, when the 
evidence of teratology was released [2, 3].  
Today, treatment with isotretinoin begins if 
other methods fail. Acne can be treated with 
topical medications, followed by antibiotics, 
and finally isotretinoin [4]. This process is 
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selected due to lower side effects as well as 
lower cost. Acne vulgaris is an 
inflammatory disease, a self-limiting 
polymorphism seen from puberty to 
adulthood due to factors such as heredity, 
hormones, immune system defects, and 
bacteria. The skin has a natural flora, 
anaerobic, and gram-positive 
Propionibacterium acnes [5-7]. 
Non-invasive treatment with isotretinoin 
(oral or ointment) is followed by antibiotic 
therapy such as tetracycline, erythromycin, 
clindamycin, and spiramycin. Roaccutane 
prevents cell division and sebaceous cell 
differentiation. The important mechanism of 
the Roaccutane is its anti-inflammatory 
effect [8-10]. 
The paraffin used for medicinal purposes 
have certain characteristics, the most 
important of which is reducing the 
percentage of excess oils. In this study, 
paraffin was chosen as the solvent due to its 
neutral properties [11, 12]. 
Clinically, the behavior of liver enzymes in 
disorders can be divided into two general 
categories: hepatocellular pattern and 
cholestatic pattern. In hepatocellular 
pattern, acute or chronic liver damage raises 
serum levels of aminotransferases. ALT and 
AST are catalysts for the transfer of alpha-
aminoase groups of aspartate and alanine to 
the alpha-ketoglutaric acid group, to 
produce oxaloacetic acid and pyruvic acid, 
respectively [13]. Concentrations of both 
enzymes in the liver are very high, but ALT 
is more specific. AST is found in the liver, 
heart, skeletal muscle, brain, kidneys, and 
red blood cells, and ALT is found in very 
small amounts in the kidneys and skeletal 
muscle and abundantly in the liver [13]. 
If Roaccutane increases the percentage of 
infertility, the mentioned problems will also 
increase. Therefore, the identification of an 
effective drug in the treatment of infertility 
and the application of the type of drug 
explains the significance of this research. 
Due to the frequent use of Roaccutane 
during and beyond puberty, its effect on the 
growth and development of ovarian follicles 
and uterine changes was the main goal of 
this research. 
2. Materials and Methods 
2.1. Animals 
     Forty healthy adult female NMRI mice 
weighing 25-30 g were purchased from the 
Pasteur Institute. They were stored on 
special plastic shelves at a temperature of 
22±2 centigrade with a humidity of 50±5. 
The mice were fed through prepared plates 
and the required water from special flasks. 
The temperature and humidity of the mice 
room were determined by a thermometer 
and a hygrometer, and during the day and 
night, the air conditioner or heater 
prevented marked temperature changes. On 
the 22
nd
 day, the mice were dissected and 
blood was taken from the heart; 
additionally, the uterine horn, ovaries, and a 




     Twenty mg/kg Roaccutane gelatin tablet 
form was obtained from Roche Company. 
The oral paraffin liquid was selected as the 
appropriate solvent. The animals received 
gavage at the doses of 5, 10, and 20 mg/kg. 
 
2.3. Blood sampling of mice and 
biopsy 
     The mice were anesthetized by 
intraperitoneal injection of 100 mg/kg 
Ketamine and 12.5 mg/kg Xylazine and the 
blood was taken from the left ventricle. 
With this method, about 1 milliliter of blood 
can be taken from the heart of each mouse. 
After the blood sampling, the uterus, ovary, 
and left lateral lobe of liver were carefully 
separated [14]. 
 
2.3.1. Hormonal measurement 
Both FSH and E2 were measured by ELISA 
(Sandwich Enzyme Immunoassay/enzyme-
linked immunosorbent assay) [15].  
 
2.3.2. Measurement of liver enzymes 
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ALP, ALT and AST were studied based on 
the kits methods (the Frankel-Reitman 
method / endpoint) using biochemical 
methods.  
 
2.4. Preparing tissue sections 
     All the necessary work was done to have 
a basic slide with haematoxylin and eosin 
(H&E) staining and then it was observed 
under a light microscope. The tissues of the 
sham group and the group1 ,2 and 3 were 
compared with the control group. 
Photographs taken for uterine tissue were 
enlarged 10 times, and for ovarian and liver 
tissues were enlarged 4 times. Measuring 
the width of the uterine layers, counting the 
total categories of ovarian follicles, 
examining the number of glands and blood 
vessels and hepatocytes were all done by 
enlarging 40 times, based on Junqueira's 
histology [16]. Measurements and counts 
were performed with the eye under a light 
microscope. 
 
2.5. Statistical analysis 
     The results were statistically analyzed 
using SPSS software (SPSS version 21.0). 
One-way ANOVA and Tukey’s were 
utilized. *P<0.05, **P< 0.01, and 
***P<0.001 were considered to be 
significant levels. The corresponding 
diagrams were drawn using Excel software. 
 
 3. Results 
Uterine  
     The statistical analysis indicated that 
following administration of higher dose of  
the drug, blood vessels and glands rose and 
also the diameter of the endometrium 
increased. The tissue results were compared 
with the control group considering the 
number of blood vessels, glands and width 
of three uterine layers. In the sham group, 
no significant changes were observed in the 
three layers of the uterus, diameter, blood 
vessels, and glands. In group 1 (Mice fed 5 
mg/kg of dissolved drug), no noticeable 
changes were observed in overall diameter 
of the ovary and glands. Yet, relatively 
minor damage to the endometrial layer and 
the formation of blood vessels was 
recorded. With increase of dose in group 2 
(Mice fed 10 mg/kg of dissolved drug), the 
layers of myometrium and perimeter were 
almost unchanged, but the width of the 
endometrial tissue showed diminution with 
dense tissue rich in blood vessels and 
glands, signifying tissue damage. In group 3 
(mice fed 20 mg/kg of dissolved drug), the 
maximum endometrial layer width and 
growth in the number of glands compared to 
previous doses were observed, but the 
number of blood vessels was approximately 
equal to group 2. Finally, an increase in the 
dose of the drug resulted in destruction of 
the endometrial layer, abnormal 
enlargement of the glands and blood 
vessels. The myometrium and perimeter 
layers showed no significant changes, and a 
slight deformation was observed in the 
overall tissue of the uterus. 
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Figure 1. The uterus histopatological results in different groups. Significant increase in glands, blood vessels and 
endometrial layer following increase of drug doses (5, 10 and 20 mg/kg) and no significant increase in premetrium and 
myometrium. Glands and blood vessels are counted at 400 magnification under a light microscope. (a: lumen b: gland c: 
blood vessel d: endometrium e: myometrium f: premetrium, H&E staining, 100x, bar: 20µm) 
 
Ovary 
As the mice took more medication, the 
ovaries progressed to maturity.  
Follicles were counted on the basis of 
primary, secondary (monolayer and bilayer 
simultaneously), graph, corpus luteum, and 
atretic. Figure 2 and 3 shows that, following 
an increase in dose of group 1 (lowest dose 
of the drug), the primary follicles were 
slightly reduced, but other follicles, glands, 
and blood vessels were observed with 
normal numbers and dimensions. In group 2 
(medium dose of the drug), an increase in 
blood vessels was observed. The nuclei of 
the cells became abnormal, and both the  
 
corpus luteum and the atrial cells were 
raised. Primary follicle cells were difficult 
to see. In the group 3 (highest dose of the 
drug), the follicles were fully mature, with 
the primitive follicles being virtually 
invisible. Compared to group 2, most 
graphic follicles became atretic. Blood 
vessels were abundant. The nuclei of the 
cells were completely degenerated. The 
final result observed in ovarian tissue was 
ovarian maturation and a significant 
reduction in the number of primary follicles 
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Figure 2. The ovarian histological results in different groups. Mice that received the highest dose of the drug had the 
most mature ovary. All follicles are counted at 400 magnification under a light microscope. (a: Primitive follicles b: 




Figure 3. Significant fall in the number of primary follicles and significant rise in the number of atretic follicles 




Tissue destruction by increasing hepatocyte 
cells, the number of glands and blood 
vessels were seen in the mice receiving the 
drug, respectively 20, 10 and 5 mg/kg of 
drug.  
Here, the number of blood vessels, glands, 
and hepatocytes were counted. Hepatic 
observations compared groups 1, 2 and 3 
and sham group with the control group 
based on the liver damage. A significant 
reduction in the number of hepatocytes, and 
a rise in the number of glands and blood 
vessels were observed. 
 
Figure 4. The liver histopatological results in different groups. A fall in the number of hepatocytes, a rise in the number 
of glands and blood vessels following an increase in drug dose (1.5-4 and 8 micro liters). Hepatocytes, glands and blood 
vessels are counted at 400 magnification under a light microscope. (a: gland b: blood vessel, 40x, H&E staining, bar: 
50µm) 
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The hormonal and enzymatic 
measurement 
E2 and FSH  
Decrease in both hormones indicates 
premature menopause. 
Significant decrease in estradiol level 
indicates sexual dysfunction, which in 
severe cases can lead to infertility. Due to 
the fact that we observed ovarian puberty, 
the mice in the middle dose and the highest 
dose, in comparison with the lowest dose, 
showed a significant reduction in estradiol, 
which means menopause. In general, since 
menopause has occurred and given the 
interpretation of the FSH test in female 
ovaries according to the stage of the 
menstrual cycle, this hormone has shown a 




Figure 5. Reduction in E2 (pg / ml) and FSH (iu / ml) following the administration of drug (5, 10 and 20 mg/kg) in 
addition to the histopatological results will accentuate ovarian maturity and premature menopause. *P<0.05, **p<0.01 as 
compared to the respective group. 
 
ALT, AST, ALP liver enzymes 
ALP in a specialized way next to ALT and 
AST shows liver tissue damage. Figure 6 
shows a significant increase referring to 
tissue damage. The rise in all three liver 
enzymes, especially the ALP which is more 
specialized than the other two, along with 
tissue evidence, indicates severe and 
significant damage in group 3 (20 mg/kg) 




Figure 6. The rise in all 3 liver enzymes (u/l) following the increase in drug doses (5, 10 and 20 mg/kg), *P<0.05 and 
**p<0.01 as compared to the respective group. 
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4. Discussion 
     The purpose of this study was 
investigating the effect of Roaccutane on 
development of ovarian follicles and uterine 
changes in adult NMRI mice strain. The 
main findings of the present study, after 
examining the tissue evidence and 
measuring enzymes and hormones, are that 
Roaccutane affects the development of 
ovarian follicles and uterine. Sex hormones 
are mainly made from cholesterol in the 
gonads (ovaries and testicles) [17]. 
Estradiol is found in a large group of female 
hormones called estrogen. Estrogen in the 
hypothalamus reduces the release of sex-
stimulating hormone and reduces the release 
of Follicle-stimulating hormone (FSH) and 
Luteinizing hormone (LH) from the 
pituitary gland [1, 17]. After menopause, 
almost no estrogen is produced in the body. 
E2 is produced in the ovaries. Women have 
a regression mechanism for this hormone, 
so that a decrease in E2 levels stimulates the 
hypothalamus and gonadotropin-releasing 
factors which, in turn, stimulate the 
pituitary gland and the secretion of FSH and 
LH hormones. These hormones stimulate 
the ovaries and produce E2. Estradiol is the 
most abundant estrogen in premenopausal 
[17]. This investigation showed that 
reduction in E2 and FSH after increase in 
the Roaccutane dose along with the 
histopatological results will precipitate 
ovarian maturity and premature menopause.  
When any damage is done to the liver 
tissue, its endocrine part is activated and 
raises the level of liver enzymes in the 
blood above its specified amount [16]. The 
liver histopatological results in this study 
beside AST, ALT and ALP measurements 
indicated severe liver damage in all the 
groups 1-3. Patients with moderate to severe 
elevations in aminotransferases have acute 
liver damage [13]. ALP is routinely tested 
but GGT is evaluated under certain 
conditions because of its high sensitivity 
and low specificity. ALP originates in 
tissues such as the placenta, kidneys, 
intestines, white blood cells, and liver [13]. 
The most common causes of pathological 
increase in ALP levels are liver and bone 
diseases [13].  
There are several studies demonstrating that 
Roaccutane induces adverse effects on 
different parts of body  [18]. It has been 
shown that the use of retinoic acid at birth 
affects ovarian development [18]. Retinoic 
acid stimulates follicle formation. After 
studying the effect of taking the drug in 
pregnant mothers, scientists found that 
babies are born with problems such as lack 
of eyes, cohesive ear layer, cleft palate, and 
respiratory gap, which require multiple and 
heavy operations if they survive [18]. 
Pregnancy blood pressure was measured 
following the use of Roaccutane in 118 
mothers, taking into account age and dose, 
of which only 11 were asymptomatic [19]. 
The use of retinoic acid after birth was 
found to affect the growth of the testis and 
the epithelium of its magnesium tubes. 
Retinoic acid affects the division of 
magnesium epithelial cells so that the 
number of germ cells is reduced by the 
effect of this substance [20]. The British 
Association of Dermatologists sought a way 
to safely introduce Roaccutaneto the 
organization's standards for improvement 
by 2012. The ovaries were in good 
condition due to the side effects of the drug 
and pregnancy tests that were taken from 
patients before, during, and after the 
treatment [21]. Scientists have concluded 
that the psychological impact of a drug 
should be investigated due to its large 
market size and availability [22]. According 
to the World Health Organization (WHO), 
the world's infertility rate has risen between 
12 to 15 percent. In Iran, the Ibn Sina 
Research Center has issued warnings from 
all over the country, announcing statistics 
above the normal global level. One of the 
most common infertility disorders is 
ovulation problems. The prevalence of this 
disorder in infertile women is 30-40%. Due 
to the importance of fertility and the need 
for positive population growth in developed 
societies and the relatively positive trend for 
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developing societies, the sensitivity of 
Roaccutane complications to infertility in 
both men and women is high. Because 
isotretinoin is widely prescribed, a large 
number of risk reduction programs have 
been implemented to prevent drug use by 
pregnant women and to prevent women 
from becoming pregnant. The most recent 
and stringent of such programs is an 
Internet-based, performance-linked system 
called iPLEDGE which tries to ensure that 
the drug is dispensed only when there is 
documentary proof that the patient is not 
pregnant and she is using two forms of birth 
control[23]. Despite the implemented 
pregnancy prevention program (PPP), 51 
out of every 10,000 pregnancies are 
exposed to isotretinoin in the Netherlands. 
Evidence from this study advises pregnant 
mothers (single or multiple) to avoid taking 
the drug for at least 30 days before 
pregnancy [24]. 
According to the Canadian pregnancy 
survey and pregnancy outcomes during 
isotretinoin treatment from 1996 to 2011, 
90.4% of pregnancies terminated 
spontaneously or ended with medical 
intervention. Congenital malformations 
were observed in 9.3% biogenesis cases 
[19].In a pilot study, it was observed that 
isotretinoin administration improves sperm 




The aim of this study was to examine the 
effect of Roaccutane on development of 
ovarian follicles and uterine changes in 
adult NMRI mice strain. Histological, 
enzymatic and hormonal studies show the 
destructive effect of Roaccutane on the 
uterus, ovaries and liver. Our experiments 
have shown that increasing the dose of the 
drug causes more harm to body. 
Unfortunately, the use of this drug during 
puberty is very high, which doubles its side 
effects. Further research in this area is 
suggested to gain more information about 
the advantages and disadvantages 
associated with this drug. 
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